Medical Cannabis in Addiction Treatment

November 1, 2018 by C. Scott McMillin

The field is getting accustomed to patients arriving in addiction treatment complaining of problems with prescription opioids, stimulants, sedatives, etc, while actively enrolled in medical cannabis programs.

Topics: , , ,


The Pain Patients’ Dilemma

October 18, 2018 by C. Scott McMillin

In the past, we’ve flung opioids at the problem, and haven’t developed alternatives.

Topics: , ,


In the News: Merchant Princes

October 15, 2018 by C. Scott McMillin

…tolerable when we’re talking about window fasteners or computer mice but surely not when the product in question directly affects our health or even our survival.

Topics: , ,


Why No Opioid Taper?

September 27, 2018 by C. Scott McMillin

Not everybody wants to remain dependent on pain medication. But at present, we offer few if any alternatives to doing it on your own.

Topics: , ,


Opioid Prescription Laws

September 3, 2018 by C. Scott McMillin

Once a problem such as opoid overprescribing is widespread, entrenched in practice, good luck eradicating it with new laws.

Topics: , ,


Worldwide Epidemic

August 2, 2018 by C. Scott McMillin

Once such substances get a foothold in a region, they’re extremely hard to eradicate.

Topics: ,


In the News: Purdue Knew

June 25, 2018 by C. Scott McMillin

Maybe they reasoned that even if they were caught out, they could avoid the worst penalties.

Topics: , ,


Tapering off Anti-Depressants

May 14, 2018 by C. Scott McMillin

In the absence of complaints, the prescriber can be tempted to assume things are going well, when in fact they aren’t.

Topics: ,


The Business of Cures

May 7, 2018 by C. Scott McMillin

I’d feel better if I knew some in our brilliant science community were working hard on ways to taper patients, if just the most highly motivated, off the medications with a reduced risk of return to heroin.

Topics: , ,


Politics and Pharmacy

April 26, 2018 by C. Scott McMillin

A number of experts pointed out the risks associated with a dramatic increase in opioid prescribing. They were ignored in favor of others who downplayed those risks.

Topics: , ,


Subscribe to RecoverySI via Email

Join 2,898 other subscribers


New Content